Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | |||||||||||||||||||||||||
net income | -85,845,000 | -22,899,000 | -80,691,000 | -44,222,000 | -125,714,000 | -148,401,000 | -134,338,000 | -141,756,000 | -146,774,000 | -144,817,000 | -117,550,000 | -95,239,000 | -88,333,000 | -73,893,000 | -51,340,000 | -36,830,000 | -75,923,000 | -120,922 | 768,880 | ||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||
depreciation and amortization | 4,184,000 | 4,359,000 | 4,413,000 | 5,086,000 | 8,066,000 | 7,156,000 | 11,932,000 | 4,549,000 | 2,987,000 | 2,192,000 | 1,830,000 | 1,739,000 | 805,000 | 1,922,000 | 908,000 | 675,000 | 657,000 | ||||||||
amortization of operating lease right-of-use assets | 1,482,000 | 1,528,000 | 1,918,000 | 2,033,000 | 2,010,000 | 1,892,000 | 1,792,000 | 1,693,000 | 1,610,000 | 1,706,000 | |||||||||||||||
amortization of discount on marketable securities | -103,000 | ||||||||||||||||||||||||
loss on marketable securities | 60,000 | -1,185,000 | 1,275,000 | -300,000 | 2,320,000 | -180,000 | 5,915,000 | -1,174,000 | 3,033,000 | ||||||||||||||||
impairment of goodwill and other intangible assets | 0 | ||||||||||||||||||||||||
impairment of long-lived assets | |||||||||||||||||||||||||
change in fair value of private warrants | 1,000 | -821,000 | -2,373,000 | -26,000 | 1,054,000 | ||||||||||||||||||||
vendor stock in lieu of cash program | 7,091,000 | 3,018,000 | 2,676,000 | ||||||||||||||||||||||
amortization of debt discount and issuance costs | 2,020,000 | 1,962,000 | 1,886,000 | 809,000 | 809,000 | 809,000 | 809,000 | 809,000 | 809,000 | 809,000 | 809,000 | 809,000 | |||||||||||||
inventory write-offs and write-downs | 1,161,000 | 1,162,000 | 2,264,000 | -604,000 | 16,903,000 | 2,204,000 | 3,911,000 | 7,981,000 | 5,451,000 | ||||||||||||||||
change in the fair value of derivatives | -2,521,000 | ||||||||||||||||||||||||
gain or write-off on sale or disposal of property and equipment | 0 | -52,000 | 290,000 | ||||||||||||||||||||||
share-based compensation, including restructuring costs | 10,469,000 | -20,657,000 | 19,380,000 | 23,343,000 | |||||||||||||||||||||
gain on extinguishment of debt | 0 | -15,281,000 | -6,775,000 | -1,314,000 | |||||||||||||||||||||
impairment of investments | |||||||||||||||||||||||||
gain from acquisition of em4 | 0 | 278,000 | -1,752,000 | ||||||||||||||||||||||
benefit from credit loss | |||||||||||||||||||||||||
gain from sale of investment | |||||||||||||||||||||||||
change in product warranty and other | 1,627,000 | 4,329,000 | 328,000 | -423,000 | |||||||||||||||||||||
changes in operating assets and liabilities: | |||||||||||||||||||||||||
accounts receivable | 4,140,000 | 10,013,000 | -14,198,000 | 975,000 | -13,846,000 | 4,778,000 | -2,094,000 | 4,242,000 | -9,877,000 | -1,313,000 | -581,000 | -2,719,000 | 9,757,000 | -11,981,000 | 2,221,000 | -301,000 | 3,828,000 | ||||||||
inventories | 783,000 | -5,293,000 | -1,570,000 | 3,332,000 | -17,586,000 | 2,298,000 | -291,000 | -13,380,000 | -11,578,000 | -3,829,000 | -3,834,000 | -2,046,000 | -768,000 | -4,093,000 | -4,018,000 | -2,198,000 | -442,000 | ||||||||
prepaid expenses and other current assets | 3,840,000 | 499,000 | 11,110,000 | -3,003,000 | -7,495,000 | 783,000 | -3,000,000 | 3,926,000 | 9,932,000 | -1,872,000 | -2,268,000 | 883,000 | -3,300,000 | -7,369,000 | -8,502,000 | -2,672,000 | -5,797,000 | ||||||||
other non-current assets | 201,000 | 16,912,000 | 866,000 | 15,830,000 | -1,071,000 | 3,635,000 | 1,829,000 | -1,131,000 | -4,156,000 | -1,918,000 | -839,000 | -690,000 | 158,000 | 82,000 | 1,402,000 | -172,000 | -1,318,000 | ||||||||
accounts payable | -8,066,000 | 1,731,000 | 7,623,000 | -9,966,000 | 6,128,000 | -361,000 | 257,000 | -7,430,000 | 11,191,000 | -3,078,000 | 987,000 | 1,409,000 | 5,983,000 | 508,000 | 2,476,000 | -912,000 | 1,766,000 | ||||||||
accrued and other current liabilities | 2,348,000 | -10,885,000 | 3,816,000 | -16,802,000 | 7,445,000 | -5,221,000 | 3,452,000 | -724,000 | 11,651,000 | 12,052,000 | 4,610,000 | -94,000 | 1,200,000 | -2,332,000 | 3,258,000 | 3,465,000 | -813,000 | ||||||||
other non-current liabilities | -1,359,000 | -13,505,000 | -2,066,000 | -9,976,000 | -2,570,000 | -1,101,000 | -588,000 | -7,143,000 | -1,488,000 | 1,536,000 | -2,640,000 | -588,000 | -343,000 | -1,922,000 | -2,436,000 | -939,000 | -720,000 | ||||||||
net cash from operating activities | -47,978,000 | -53,725,000 | -44,229,000 | -61,938,000 | -81,229,000 | -52,778,000 | -56,543,000 | -73,309,000 | -64,674,000 | -74,673,000 | -48,361,000 | -52,361,000 | -32,837,000 | -54,165,000 | -36,073,000 | -30,169,000 | -28,014,000 | 875,556 | |||||||
capex | -797,000 | 211,000 | 951,000 | -846,000 | -985,000 | -2,154,000 | -7,543,000 | -7,690,000 | -3,702,000 | -2,130,000 | -4,753,000 | -1,807,000 | -3,054,000 | -2,278,000 | -1,124,000 | -2,103,000 | -385,000 | 0 | |||||||
free cash flows | -48,775,000 | -53,514,000 | -43,278,000 | -62,784,000 | -82,214,000 | -54,932,000 | -64,086,000 | -80,999,000 | -68,376,000 | -76,803,000 | -53,114,000 | -54,168,000 | -35,891,000 | -56,443,000 | -37,197,000 | -32,272,000 | -28,399,000 | 875,556 | |||||||
cash flows from investing activities: | |||||||||||||||||||||||||
purchases of marketable securities | 74,000 | -19,607,000 | -34,547,000 | -38,004,000 | -48,827,000 | -32,329,000 | -98,046,000 | -89,495,000 | -81,623,000 | -40,692,000 | -93,466,000 | -76,753,000 | -193,687,000 | -186,754,000 | -153,890,000 | -150,044,000 | -226,245,000 | ||||||||
proceeds from maturities of marketable securities | 38,220,000 | 40,536,000 | 40,224,000 | 23,095,000 | 88,990,000 | 129,450,000 | 113,065,000 | 129,426,000 | 148,345,000 | 113,299,000 | 107,015,000 | 55,599,000 | 91,454,000 | 59,950,000 | 137,288,000 | 100,344,000 | 69,275,000 | ||||||||
proceeds from sales/redemptions of marketable securities | 1,704,000 | 102,000 | 14,388,000 | -316,000 | 274,000 | 787,000 | 12,417,000 | 18,987,000 | 20,165,000 | ||||||||||||||||
issuance of promissory notes | |||||||||||||||||||||||||
proceeds from sales of equity investment | |||||||||||||||||||||||||
purchases of property and equipment | -540,000 | -111,000 | -115,000 | -846,000 | -1,284,000 | -786,000 | -4,298,000 | -5,151,000 | -11,680,000 | -4,337,000 | -3,786,000 | -2,487,000 | -5,004,000 | -2,278,000 | -1,445,000 | -1,821,000 | -889,000 | ||||||||
acquisition of em4 | 0 | 0 | 242,000 | 300,000 | -4,727,000 | ||||||||||||||||||||
proceeds from disposal of property and equipment | 0 | 52,000 | 253,000 | ||||||||||||||||||||||
net cash from investing activities | 40,266,000 | 20,972,000 | 20,445,000 | -15,636,000 | 34,426,000 | 97,122,000 | 23,138,000 | 53,767,000 | 62,599,000 | 87,066,000 | 27,916,000 | 7,399,000 | -94,395,000 | -50,612,000 | 28,867,000 | -44,089,000 | -128,354,000 | -1,263,655 | |||||||
cash flows from financing activities: | |||||||||||||||||||||||||
net proceeds from issuance of class a common stock under the equity financing program | 14,692,000 | 21,067,000 | 394,000 | 47,553,000 | 17,230,000 | 11,479,000 | 9,107,000 | 6,939,000 | 22,665,000 | ||||||||||||||||
proceeds from sale of class a common stock under espp | 0 | 353,000 | 1,235,000 | 0 | |||||||||||||||||||||
proceeds from exercise of stock options | 1,000 | 371,000 | 501,000 | 990,000 | 534,000 | 1,036,000 | 1,095,000 | 1,100,000 | 699,000 | 1,092,000 | 1,121,000 | 1,926,000 | 2,491,000 | 321,000 | |||||||||||
payments of employee taxes related to stock-based awards | -794,000 | -86,000 | -110,000 | -1,757,000 | -126,000 | -1,565,000 | 0 | 0 | -572,000 | -957,000 | -1,049,000 | ||||||||||||||
proceeds from issuance of senior notes, net of senior notes and 2030 convertible notes issuance costs | 0 | ||||||||||||||||||||||||
repurchase of 2026 convertible senior notes | 0 | ||||||||||||||||||||||||
proceeds from issuance of series a preferred stock, net of issuance costs, discount and commitment fees | 0 | ||||||||||||||||||||||||
net cash from financing activities | 13,898,000 | 22,437,000 | 284,000 | 46,150,000 | 17,475,000 | 18,092,000 | 20,097,000 | 18,879,000 | 23,129,000 | 1,409,000 | 51,000 | -37,467,000 | -43,344,000 | 305,431,000 | 1,840,000 | 2,217,000 | 154,104,000 | ||||||||
net decrease in cash, cash equivalents and restricted cash | 6,186,000 | -20,394,000 | -82,429,000 | -170,576,000 | |||||||||||||||||||||
beginning cash, cash equivalents and restricted cash | 0 | 0 | 84,722,000 | 0 | 140,624,000 | 0 | 0 | 0 | 71,105,000 | 0 | 0 | 0 | 330,702,000 | 0 | 0 | ||||||||||
ending cash, cash equivalents and restricted cash | 6,186,000 | -10,316,000 | 61,222,000 | 111,296,000 | 62,436,000 | -13,308,000 | -663,000 | 92,159,000 | 13,802,000 | -20,394,000 | -82,429,000 | 160,126,000 | 200,654,000 | -5,366,000 | |||||||||||
supplemental disclosures of cash flow information: | |||||||||||||||||||||||||
cash paid for interest | 8,947,000 | 10,634,000 | 9,898,000 | 3,907,000 | 0 | 3,906,000 | 0 | 16,000 | 18,000 | 19,000 | |||||||||||||||
supplemental disclosures of noncash investing and financing activities: | |||||||||||||||||||||||||
conversion of 2030 convertible notes to class a common stock | 0 | 0 | 1,127,000 | ||||||||||||||||||||||
conversion of 2026 convertible senior notes to class a common stock | 0 | 4,286,000 | 11,819,000 | ||||||||||||||||||||||
conversion of series a preferred stock to class a common stock | 24,523,000 | ||||||||||||||||||||||||
deemed dividend on series a preferred stock | -3,682,000 | ||||||||||||||||||||||||
recognition/(derecognition) of operating lease right-of-use asset and liability | 0 | ||||||||||||||||||||||||
purchases of property and equipment recorded in accounts payable and accrued liabilities | -257,000 | 322,000 | 1,066,000 | 299,000 | -1,368,000 | -3,245,000 | -2,539,000 | 7,978,000 | 2,207,000 | -967,000 | 680,000 | 1,950,000 | 321,000 | -282,000 | 504,000 | ||||||||||
amortization of premium (discount) on marketable securities | -494,000 | -870,000 | -1,977,000 | -2,341,000 | -868,000 | -743,000 | 262,000 | ||||||||||||||||||
change in the fair value of the derivatives | 3,671,000 | ||||||||||||||||||||||||
income from acquisition of em4 | 48,000 | ||||||||||||||||||||||||
net increase in cash, cash equivalents and restricted cash | -23,500,000 | -31,424,000 | -29,328,000 | 62,436,000 | -13,308,000 | -663,000 | 21,054,000 | 200,654,000 | |||||||||||||||||
recognition/derecognition of operating lease right-of-use asset and liability | |||||||||||||||||||||||||
losses and impairments on non-marketable securities and certain other assets | 0 | ||||||||||||||||||||||||
change in fair value of warrants | -2,577,000 | 1,231,000 | -11,733,000 | 3,857,000 | -17,072,000 | -6,928,000 | 46,649,000 | ||||||||||||||||||
deferred taxes | 2,000 | ||||||||||||||||||||||||
acquisition of freedom photonics llc | 0 | ||||||||||||||||||||||||
acquisition of certain assets from solfice research, inc. | 0 | ||||||||||||||||||||||||
acquisition of seagate’s lidar business | 0 | 0 | 0 | -12,608,000 | |||||||||||||||||||||
advances for capital projects and equipment | -441,000 | -336,000 | |||||||||||||||||||||||
proceeds from issuance of class a common stock to a wholly owned subsidiary of tpk | 10,000,000 | ||||||||||||||||||||||||
proceeds from a financing transaction | |||||||||||||||||||||||||
repurchases of common stock and redemption of warrants | |||||||||||||||||||||||||
amortization of premium/discount on marketable securities | |||||||||||||||||||||||||
vendor stock-in-lieu of cash program | 4,034,000 | 19,342,000 | 10,373,000 | 15,430,000 | 5,684,000 | 8,972,000 | 12,571,000 | 12,068,000 | 7,848,000 | ||||||||||||||||
changes in fair value of derivative liability | |||||||||||||||||||||||||
amortization of debt premium/discount and issuance costs | |||||||||||||||||||||||||
conversion of 2030 convertible notes to equity | |||||||||||||||||||||||||
vendor stock-in-lieu of cash program—advances for capital projects and equipment | 1,140,000 | 3,166,000 | 1,725,000 | 2,520,000 | 7,378,000 | 10,731,000 | |||||||||||||||||||
investment in plus | |||||||||||||||||||||||||
share-based compensation | 44,465,000 | 47,101,000 | 44,882,000 | 59,195,000 | 55,954,000 | 44,531,000 | 52,551,000 | 38,625,000 | 26,698,000 | 27,797,000 | 33,520,000 | 14,530,000 | 1,837,000 | ||||||||||||
product warranty and other | -1,684,000 | 1,189,000 | 2,498,000 | 586,000 | -794,000 | 64,000 | 107,000 | ||||||||||||||||||
operating lease right-of-use assets obtained in exchange for lease obligations | 3,842,000 | 25,112,000 | 387,000 | 1,737,000 | 1,211,000 | 0 | 6,756,000 | 4,247,000 | 5,746,000 | 0 | 0 | 2,876,000 | |||||||||||||
write-off or loss on sale or disposal of property and equipment | |||||||||||||||||||||||||
impairment of goodwill and intangible assets | |||||||||||||||||||||||||
expense related to volvo warrants | |||||||||||||||||||||||||
product warranty | |||||||||||||||||||||||||
other | -578,000 | 371,000 | -63,000 | 575,000 | |||||||||||||||||||||
cash received from acquisition of optogration, inc. | 0 | ||||||||||||||||||||||||
disposal of property and equipment | |||||||||||||||||||||||||
proceeds from issuance of class a common stock to a tpk group company | |||||||||||||||||||||||||
proceeds from issuance of convertible senior notes, net of debt discounts of 15,625 | |||||||||||||||||||||||||
purchases of capped call options | |||||||||||||||||||||||||
repayment of debt | 47,000 | -16,000 | -68,000 | -75,000 | |||||||||||||||||||||
principal payments on finance leases | -76,000 | -67,000 | |||||||||||||||||||||||
proceeds from exercise of warrants | 0 | 0 | 0 | 153,927,000 | |||||||||||||||||||||
other financing activities | 215,000 | ||||||||||||||||||||||||
issuance of class a common stock upon exercise of warrants | 0 | 0 | 314,000 | 18,689,000 | 0 | 0 | 338,293,000 | ||||||||||||||||||
issuance of class a common stock for investment in plus | |||||||||||||||||||||||||
issuance of class a common stock for investment in robotic research opco, llc | |||||||||||||||||||||||||
issuance of class a common stock to acquire optogration, inc. | |||||||||||||||||||||||||
operating lease right-of-use assets obtained in exchange for lease obligations upon adoption of asc 842 | 0 | 0 | 10,849,000 | ||||||||||||||||||||||
amounts payable for shares repurchased | |||||||||||||||||||||||||
investment in ecarx holdings, inc. | |||||||||||||||||||||||||
loss on investment in non-marketable securities | |||||||||||||||||||||||||
acquisition of certain assets from solfice | |||||||||||||||||||||||||
repurchase of common stock | |||||||||||||||||||||||||
amortization of premium on marketable securities | 177,000 | 192,000 | 475,000 | 444,000 | |||||||||||||||||||||
loss on sale or disposal of property and equipment | |||||||||||||||||||||||||
loss on extinguishment of debt | |||||||||||||||||||||||||
impairment of investments and certain other assets | |||||||||||||||||||||||||
warranty related to sensors | 299,000 | ||||||||||||||||||||||||
proceeds from refundable security deposits | |||||||||||||||||||||||||
cash received from gores on recapitalization | |||||||||||||||||||||||||
transaction costs related to merger with gores | |||||||||||||||||||||||||
proceeds from issuance of series x convertible preferred stock | |||||||||||||||||||||||||
issuance cost paid for series x convertible preferred stock | |||||||||||||||||||||||||
proceeds from the issuance of debt | |||||||||||||||||||||||||
debt prepayment charges | |||||||||||||||||||||||||
debt issuance costs | |||||||||||||||||||||||||
conversion of series a, series x and founders’ convertible preferred stock into class a and class b common stock | |||||||||||||||||||||||||
assets acquired under finance leases | |||||||||||||||||||||||||
impairment of inventories | 3,972,000 | 3,422,000 | 1,356,000 | 1,317,000 | 148,000 | 1,196,000 | 257,000 | ||||||||||||||||||
proceeds from sales of marketable securities | 18,489,000 | 37,473,000 | 12,842,000 | 46,556,000 | 7,432,000 | 29,505,000 | |||||||||||||||||||
repurchase of common stock and redemption of warrants | 0 | -36,958,000 | -43,920,000 | 0 | -2,000 | ||||||||||||||||||||
noncash lease expense related to operating lease right-of-use assets | 1,254,000 | 885,000 | |||||||||||||||||||||||
acquisition of freedom photonics | |||||||||||||||||||||||||
acquisition of solfice assets | |||||||||||||||||||||||||
receivable from stock option exercises | |||||||||||||||||||||||||
payments of employee taxes related to vested restricted stock units | -516,000 | ||||||||||||||||||||||||
deferred financing costs recorded in accrued liabilities | 223,000 | ||||||||||||||||||||||||
noncash lease expense relating to operating lease right-of-use assets | |||||||||||||||||||||||||
change in fair value of warrants and safe liabilities | |||||||||||||||||||||||||
settlement of safe notes | |||||||||||||||||||||||||
proceeds from issuance of series a convertible preferred stock | |||||||||||||||||||||||||
proceeds from issuance of safe notes | |||||||||||||||||||||||||
proceeds from issuance of restricted common stock | |||||||||||||||||||||||||
share-based compensation—vendor payments | |||||||||||||||||||||||||
merger related expense recorded in accounts payable and accrued liabilities | |||||||||||||||||||||||||
issuance cost for series x preferred stock recorded in accounts payable | |||||||||||||||||||||||||
noncash lease expense related to operating right-of-use assets | 858,000 | 890,000 | |||||||||||||||||||||||
unrealized loss on marketable securities | -218,000 | 278,000 | |||||||||||||||||||||||
cash received from gores on settlement of recapitalization of escrow | |||||||||||||||||||||||||
net decrease in cash and cash equivalents, and restricted cash and cash equivalents | -2,264,000 | ||||||||||||||||||||||||
beginning cash and cash equivalents, and restricted cash and cash equivalents | 209,719,000 | ||||||||||||||||||||||||
ending cash and cash equivalents, and restricted cash and cash equivalents | 207,455,000 | ||||||||||||||||||||||||
loss on disposal of property and equipment | |||||||||||||||||||||||||
principal payments on capital leases | |||||||||||||||||||||||||
net increase in cash and cash equivalents, and restricted cash and cash equivalents | |||||||||||||||||||||||||
conversion of bridge note into series a convertible preferred stock | |||||||||||||||||||||||||
conversion of safe notes into common stock | |||||||||||||||||||||||||
conversion of safe notes into series a convertible preferred stock | |||||||||||||||||||||||||
assets acquired on capital leases | |||||||||||||||||||||||||
net income/ | |||||||||||||||||||||||||
changes in state franchise tax accrual | 10,000 | -30,000 | -150,000 | ||||||||||||||||||||||
changes in prepaid assets and deferred costs | 48,040 | 47,700 | -18,801 | ||||||||||||||||||||||
changes in deferred offering costs | |||||||||||||||||||||||||
changes in accrued expenses, formation and offering costs | 2,850,008 | 7,703 | 24,982 | ||||||||||||||||||||||
changes in current income tax and interest payable | -61,650 | ||||||||||||||||||||||||
changes in deferred income tax | 15,079 | -12,471 | -255 | ||||||||||||||||||||||
net cash provided by/(used in) operating activities | -1,164,938 | ||||||||||||||||||||||||
cash deposited in trust account | |||||||||||||||||||||||||
interest reinvested in trust account | 672,417 | 1,301,002 | -1,263,655 | ||||||||||||||||||||||
net cash provided by/(used in) investing activities | 672,417 | ||||||||||||||||||||||||
proceeds from sale of units in initial public offering | |||||||||||||||||||||||||
proceeds from sale of private placement warrants to sponsor | |||||||||||||||||||||||||
repayment of notes and advances payable – related party | |||||||||||||||||||||||||
payment of underwriters’ discounts and commissions | |||||||||||||||||||||||||
payment of accrued offering costs | |||||||||||||||||||||||||
increase/(decrease) in cash | -492,521 | ||||||||||||||||||||||||
cash at beginning of period | 0 | 0 | 1,365,240 | ||||||||||||||||||||||
cash at end of period | -492,521 | 34,254 | 977,141 | ||||||||||||||||||||||
supplemental disclosure of cash and non-cash financing activities: | |||||||||||||||||||||||||
deferred underwriting compensation | |||||||||||||||||||||||||
cash paid for income and state franchise taxes | 40,000 | 1,219,086 | 200,050 | ||||||||||||||||||||||
basic and diluted net income/(loss) per share: | |||||||||||||||||||||||||
numerator: | |||||||||||||||||||||||||
allocation of net income/ | -3,130,332 | -953,358 | 867,835 | -360,272 | 942,603 | 1,044,989 | |||||||||||||||||||
denominator: | |||||||||||||||||||||||||
weighted-average shares outstanding | 0 | 0 | 40,000,000 | 0 | 1,555,599,999,340,312 | 2,444,400,010,659,688 | |||||||||||||||||||
basic and diluted net income/(loss) per share | -0.08 | -0.02 | 0.02 | -0.01 | 0.01 | 0.04 | |||||||||||||||||||
accrued expenses, formation, and offering costs | |||||||||||||||||||||||||
changes in current income tax and interest | 250,750 | ||||||||||||||||||||||||
increase in cash | -388,099 | ||||||||||||||||||||||||
changes in prepaid assets | |||||||||||||||||||||||||
changes in current income tax | |||||||||||||||||||||||||
proceeds from notes and advances payable - related party | |||||||||||||||||||||||||
proceeds from sale of class f common stock to sponsor | |||||||||||||||||||||||||
payment of underwriter's discounts and commissions | |||||||||||||||||||||||||
supplemental disclosure of non-cash financing activities: | |||||||||||||||||||||||||
1. |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
